Company Filing History:
Years Active: 2012
Title: Innovations by Shin-Kuang Chen in Esophageal Cancer Treatment
Introduction
Shin-Kuang Chen is an inventor based in Taipei City, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His work focuses on identifying genetic markers that can predict how patients with esophageal cancer respond to chemoradiotherapy.
Latest Patent Applications
Shin-Kuang Chen's notable patent application is titled "Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy." This invention relates to novel genetic markers associated with the response of a patient with esophageal cancer to chemoradiation therapy. The application emphasizes methods and kits for predicting an esophageal cancer patient's response to treatment through the genotyping of these markers.
Conclusion
Shin-Kuang Chen's innovative approach to understanding the genetic factors influencing treatment responses in esophageal cancer patients highlights the potential for personalized medicine in oncology. His work may pave the way for more effective treatment strategies in the future.